Drug Topics

JULY 12, 2024

Global coverage for diphtheria, tetanus, and pertussis has reached its lowest point in 15 years.

Vaccines 200

Vaccines 200

Pharmacy Times

JULY 12, 2024

Results show that daily injections of buprenorphine over a 7-day period was safe and well-tolerated in patients who had Clinical Opioid Withdrawal Scale scores of 4 to 7.

139

139

STAT

JULY 12, 2024

This week, the late National Hockey League veteran Greg Johnson was diagnosed with chronic traumatic encephalopathy, or CTE. Johnson died by suicide five years ago at the age of 48, having played 14 seasons in the NHL. It’s the latest sign of the prevalence of CTE, a progressive neurodegenerative disease caused by repeated impacts to the head, in professional contact sports.

128

128

Pharmacy Times

JULY 12, 2024

Helping patients overcome barriers to accessing these treatments is a vital role for pharmacists, who can support patients who are looking to quit.

145

145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

JULY 12, 2024

ONC's HTI-2 proposed rule 'big step forward' for interoperability, health IT experts say, but EHR vendors concerned about timelines hlandi Fri, 07/12/2024 - 14:43

129

129

Fierce Pharma

JULY 12, 2024

Trials have already shown that Novo Nordisk’s semaglutide | Trials have already shown that Novo Nordisk’s semaglutide can cut the risk of cardiovascular events and kidney disease. Now a study from the University of Oxford indicates that the company’s semaglutide type 2 diabetes drug Ozempic can reduce the risk of dementia compared with another popular diabetes medicine.

118

118

Drug Topics

JULY 12, 2024

Researchers aimed to address the extent of stigmatization’s effect on the mental health of adolescents with chronic skin disorders.

112

112

Fierce Healthcare

JULY 12, 2024

Initially meant to protect patients from unnecessary procedures, prior authorizations have shifted towards being a cost containment strategy for health payers. | Regulations and policies are moving the industry in the right direction, but there is still room for improvement in key areas where regulations don't go far enough.

111

111

STAT

JULY 12, 2024

Researchers were perplexed when the Food and Drug Administration announced it was investigating whether CAR-T therapy, one of the most effective treatments for blood cancers, could cause lymphoma. This was always a theoretical risk of genetically engineered therapies like CAR-T, but it never materialized in the decades after the technology’s birth.

FDA 109

FDA 109

The Checkup by Singlecare

JULY 12, 2024

L-carnitine is a common form of carnitine , an amino acid found in animal products, especially red meat. A vegan diet may be low in carnitine content. According to the National Institutes of Health (NIH), it is also naturally produced in the human liver, kidneys, and brain. It is found in the highest concentrations in the brain and skeletal muscle. L-carnitine is vital for mitochondria function and fatty acid oxidation—essentially, it helps with energy production by transforming fat into fuel fo

Dosage 105

Dosage 105

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JULY 12, 2024

Grave warnings of a crisis in maternal deaths are being slightly eroded by articles suggesting that advocates overreached and that the “crisis” was primarily a function of measurement error. Both sides are partially right, because measuring maternal mortality is uniquely challenging. The question at the heart of identifying a maternal death — “Would this person have died if she hadn’t been pregnant?

Medical Records 104

Medical Records 104

pharmaphorum

JULY 12, 2024

A new payment policy proposal released by the Centers for Medicare and Medicaid Services (CMS) this week covers digital tools used for behavioural health, which could be a boost for the digital health sector.The Medicare Physician Fee Schedule (PFS) sets out the method of payment, rates, and codes for healthcare providers participating in Medicare, and is often used by the administration as an instrument to encourage some forms of healthcare intervention.

101

101

STAT

JULY 12, 2024

Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more personalized, precise, patient-focused care. A similar approach needs to be implemented at scale for clinical trials. Over the past decade, precision medicine has evolved from merely creating personalized treatment plans and delivery methods to being integral throughout the entire drug development process.

103

103

Pharmacy Times

JULY 12, 2024

An analysis of interaction checkers and product summaries revealed large differences in the consistency and reliability of providing accurate information on potential drug-drug interactions.

132

132

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

JULY 12, 2024

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We hope to catch up on our reading, promenade with the official mascots, and stop by a favorite festival. We may also hold another listening party, where the rotation will likely include this , this , this , this and this.

Insurance 96

Insurance 96

Pharmacy Times

JULY 12, 2024

Unique gut flora were found in children with autism spectrum disorder (ASD).

139

139

STAT

JULY 12, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello! Today, we talk about an Illumina competitor’s newest influx of funding, Adam weighs in on Pfizer’s plan for a once-a-day GLP-1 pill, and more.

FDA 95

FDA 95

Fierce Pharma

JULY 12, 2024

Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the future—despite a few promising growth opportunities the team has identified. | Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the drugmaker—despite a few promising growth opportunities they identified.

93

93

PharmaVoice

JULY 12, 2024

Patent disputes in the U.S. and abroad have opened the door to new generics ready for launch as soon as September for BMS’ Sprycel.

105

105

pharmaphorum

JULY 12, 2024

Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category – but has now decided on a lead candidate.The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later this year.

91

91

Pharmacy Times

JULY 12, 2024

Jeffrey Goad discusses key considerations for travelers regarding medications, maintaining medication schedules across time zones, ensuring proper vaccinations, and the importance of consulting health care professionals before international trips.

Vaccines 81

Vaccines 81

pharmaphorum

JULY 12, 2024

Stay informed about the upcoming EU Artificial Intelligence Act, which will regulate AI use in compliance with EU standards. Learn how this legislation may impact your organisation's AI initiatives.

88

88

Pharmacy Times

JULY 12, 2024

Pharmacists’ awareness of respiratory syncytial virus and their role in educating about the vaccine have grown dramatically.

Vaccines 139

Vaccines 139

pharmaphorum

JULY 12, 2024

New UK Health Secretary Wes Streeting orders a 'raw and frank' review of NHS to inform a new 10-year plan to fix it

103

103

Pharmaceutical Technology

JULY 12, 2024

The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.

Hospitals 111

Hospitals 111

Fierce Pharma

JULY 12, 2024

Even through an onslaught of biosimilar launches that began early last year, AbbVie’s big-selling Humira has been able to retain most of its lucrative market. | With ten biosimilar options in play, AbbVie's star immunology drug lost 13% of its total market share since March, according to a new Samsung Bioepis report.

83

83

pharmaphorum

JULY 12, 2024

Learn how to effectively connect the clinical, regulatory, and commercial aspects in the development of treatments for rare diseases. Discover strategies and insights for navigating the unique challenges of rare disease drug development.

83

83

Pharmaceutical Technology

JULY 12, 2024

Ipsen has entered an exclusive global licensing agreement with Foreseen Biotech for FS001, a potentially first-in-class ADC.

98

98

pharmaphorum

JULY 12, 2024

Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round

100

100

STAT

JULY 12, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

79

79

Outsourcing Pharma

JULY 12, 2024

Blow-fill-seal (BFS) technology has long been a cornerstone of pharmaceutical manufacturing, relied on for packaging sterile liquid medications, including but not limited to ophthalmic and respiratory drug products.

Packaging 75

Packaging 75

Drug Topics

JULY 12, 2024

Pfizer joins Eli Lilly and Novo Nordisk in the development of oral GLP-1 receptor agonist candidates.

112

112

Pharmacy Times

JULY 12, 2024

Alan Chin, PharmD, BCOP, examines the PALOMA-3 trial's influence on the treatment of EGFR-mutated metastatic NSCLC and explores the evolving role of antibody-drug conjugates (ADCs) in the therapeutic landscape of EGFR-mutated NSCLC.

65

65

Outsourcing Pharma

JULY 12, 2024

Cellibre, a leader in sustainable biochemical manufacturing, has secured a $2 million grant from the National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH).

71

71